

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95937966 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.95937966 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.78981764 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.61607986 |
| 5 | detection of other organism (GO:0098543) | 4.58109025 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 4.37662006 |
| 7 | detection of bacterium (GO:0016045) | 4.25306790 |
| 8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.20429296 |
| 9 | microglial cell activation (GO:0001774) | 4.19280330 |
| 10 | detection of external biotic stimulus (GO:0098581) | 4.04524885 |
| 11 | leukocyte aggregation (GO:0070486) | 4.03652778 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00478798 |
| 13 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.93477749 |
| 14 | positive regulation of mast cell degranulation (GO:0043306) | 3.93477749 |
| 15 | B cell mediated immunity (GO:0019724) | 3.89240345 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.81204250 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.78231761 |
| 18 | response to host immune response (GO:0052572) | 3.76011700 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76011700 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58897339 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55241972 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.54683881 |
| 23 | detection of biotic stimulus (GO:0009595) | 3.53119341 |
| 24 | regulation of mast cell activation (GO:0033003) | 3.51260650 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.48723517 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48048764 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45688907 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.42955349 |
| 29 | macrophage activation (GO:0042116) | 3.42879076 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.40618776 |
| 31 | regulation of tolerance induction (GO:0002643) | 3.39439608 |
| 32 | positive regulation of lamellipodium assembly (GO:0010592) | 3.35343547 |
| 33 | respiratory burst (GO:0045730) | 3.35189507 |
| 34 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.31222917 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29739101 |
| 36 | response to host (GO:0075136) | 3.28181895 |
| 37 | response to host defenses (GO:0052200) | 3.28181895 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28181895 |
| 39 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.27546157 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26501478 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16395811 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15456561 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11220877 |
| 44 | activated T cell proliferation (GO:0050798) | 3.09390433 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.07669938 |
| 46 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07087771 |
| 47 | response to interleukin-15 (GO:0070672) | 3.06917702 |
| 48 | mast cell activation (GO:0045576) | 3.06382843 |
| 49 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04423963 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 3.01547721 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 3.00516217 |
| 52 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99318039 |
| 53 | mast cell degranulation (GO:0043303) | 2.98055503 |
| 54 | mast cell activation involved in immune response (GO:0002279) | 2.98055503 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.96337103 |
| 56 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.96012867 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 2.95967301 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95058969 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 2.95051379 |
| 60 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93775430 |
| 61 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.90957967 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.90226348 |
| 63 | response to muramyl dipeptide (GO:0032495) | 2.88827234 |
| 64 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.88318624 |
| 65 | synaptic vesicle exocytosis (GO:0016079) | 2.87772115 |
| 66 | cellular response to interferon-gamma (GO:0071346) | 2.86633301 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 2.85509015 |
| 68 | positive T cell selection (GO:0043368) | 2.85309442 |
| 69 | T cell migration (GO:0072678) | 2.85024080 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.84830343 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84830343 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.84830343 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84830343 |
| 74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84830343 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84830343 |
| 76 | negative thymic T cell selection (GO:0045060) | 2.83375093 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83260850 |
| 78 | neutrophil mediated immunity (GO:0002446) | 2.82912813 |
| 79 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82780070 |
| 80 | regulation of hypersensitivity (GO:0002883) | 2.81615309 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.81583673 |
| 82 | myeloid leukocyte activation (GO:0002274) | 2.81027105 |
| 83 | negative regulation of B cell proliferation (GO:0030889) | 2.80767584 |
| 84 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79779672 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78803523 |
| 86 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78803523 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78555083 |
| 88 | cellular extravasation (GO:0045123) | 2.78247190 |
| 89 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.78028536 |
| 90 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77386470 |
| 91 | negative T cell selection (GO:0043383) | 2.77196136 |
| 92 | positive regulation of lamellipodium organization (GO:1902745) | 2.76953255 |
| 93 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76069855 |
| 94 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75759206 |
| 95 | response to protozoan (GO:0001562) | 2.75634124 |
| 96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74380861 |
| 97 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.70201232 |
| 98 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.67425378 |
| 99 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.67425378 |
| 100 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.67425378 |
| 101 | neutrophil activation (GO:0042119) | 2.66867478 |
| 102 | exploration behavior (GO:0035640) | 2.66749653 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.64360141 |
| 104 | actin nucleation (GO:0045010) | 2.60271132 |
| 105 | immunoglobulin mediated immune response (GO:0016064) | 2.58028549 |
| 106 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.56093756 |
| 107 | positive regulation of Rap GTPase activity (GO:0032854) | 2.55653992 |
| 108 | tolerance induction (GO:0002507) | 2.53533680 |
| 109 | clathrin coat assembly (GO:0048268) | 2.53140586 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 2.52584995 |
| 111 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.52108172 |
| 112 | granulocyte activation (GO:0036230) | 2.50234233 |
| 113 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49787304 |
| 114 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.49110719 |
| 115 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.48896859 |
| 116 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.48382339 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.48343419 |
| 118 | leukocyte degranulation (GO:0043299) | 2.48253554 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.47634166 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 2.47530048 |
| 121 | cellular response to zinc ion (GO:0071294) | 2.46867193 |
| 122 | regulation of Rap GTPase activity (GO:0032317) | 2.46088052 |
| 123 | negative regulation of microtubule polymerization (GO:0031115) | 2.45214046 |
| 124 | regulation of defense response to virus by virus (GO:0050690) | 2.45114307 |
| 125 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.41405959 |
| 126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37878566 |
| 127 | interferon-gamma production (GO:0032609) | 2.37708363 |
| 128 | regulation of synaptic vesicle transport (GO:1902803) | 2.36939370 |
| 129 | T cell costimulation (GO:0031295) | 2.36818591 |
| 130 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36660176 |
| 131 | response to fungus (GO:0009620) | 2.36558560 |
| 132 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.35830150 |
| 133 | positive thymic T cell selection (GO:0045059) | 2.35473867 |
| 134 | defense response to protozoan (GO:0042832) | 2.33848481 |
| 135 | lymphocyte costimulation (GO:0031294) | 2.33705257 |
| 136 | response to peptidoglycan (GO:0032494) | 2.33415337 |
| 137 | mature B cell differentiation (GO:0002335) | 2.32859554 |
| 138 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.30491946 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.30108564 |
| 140 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.27705813 |
| 141 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.27554928 |
| 142 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.27554928 |
| 143 | T cell homeostasis (GO:0043029) | 2.26752308 |
| 144 | myeloid dendritic cell activation (GO:0001773) | 2.25913503 |
| 145 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.25023422 |
| 146 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.24615297 |
| 147 | neutrophil chemotaxis (GO:0030593) | 2.23268724 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.22536353 |
| 149 | regulation of leukocyte degranulation (GO:0043300) | 2.22236840 |
| 150 | glutamate secretion (GO:0014047) | 2.21061013 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.20842566 |
| 152 | neuron cell-cell adhesion (GO:0007158) | 2.20551104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.06990891 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.92419140 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.79642146 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76642562 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66626734 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54383779 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.37410164 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.92293510 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.85443149 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83225977 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69239073 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65310752 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61465431 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.60058912 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59707491 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51361706 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45336981 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45197196 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.34577266 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30058236 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29644242 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.28972311 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28504497 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25054172 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24631514 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20142570 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.19715816 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.19416463 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18709484 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.18126020 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16473438 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13719186 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11409365 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.10517579 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02504033 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.96923606 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.95258009 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94611107 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92791110 |
| 40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91548100 |
| 41 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88062259 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.82977306 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81663657 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81107036 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.80005239 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78299757 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77595783 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76716948 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73769311 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69374682 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68858007 |
| 52 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53587379 |
| 53 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.51577683 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40786570 |
| 55 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40579595 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34348274 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31942156 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.30390748 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29464952 |
| 60 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28775941 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25863445 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24675325 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24415814 |
| 64 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.24036781 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23348262 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23012613 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21984769 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21371058 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19750060 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18428855 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18176224 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15634155 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13899375 |
| 74 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11761064 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11564604 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11291575 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11147179 |
| 78 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09850866 |
| 79 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09628466 |
| 80 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08321831 |
| 81 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08109189 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07038736 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05987979 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04293361 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03907276 |
| 86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03683848 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02800968 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02485041 |
| 89 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01620763 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00785259 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98470806 |
| 92 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98445407 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97275347 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93629039 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91040364 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88289754 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88215147 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87952784 |
| 99 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.87697036 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86811407 |
| 101 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.84764868 |
| 102 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84062491 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83831629 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83072733 |
| 105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82013108 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81377684 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81335009 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81235439 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81035683 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80558587 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79921546 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79455288 |
| 113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.79225471 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78976685 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77641007 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77261095 |
| 117 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77121108 |
| 118 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76314275 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76261359 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76157664 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76078403 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.75933020 |
| 123 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75388699 |
| 124 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75235451 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75153312 |
| 126 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.74261755 |
| 127 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.73863386 |
| 128 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.71655932 |
| 129 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71300799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.71727643 |
| 2 | MP0003303_peritoneal_inflammation | 3.62622369 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.09607117 |
| 4 | MP0005671_abnormal_response_to | 2.75694012 |
| 5 | MP0003880_abnormal_central_pattern | 2.62520139 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.34822479 |
| 7 | MP0001800_abnormal_humoral_immune | 2.30418297 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.26996446 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.14524114 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.12419211 |
| 11 | MP0001819_abnormal_immune_cell | 2.11969367 |
| 12 | MP0003436_decreased_susceptibility_to | 2.11331522 |
| 13 | MP0000685_abnormal_immune_system | 2.07876482 |
| 14 | MP0008260_abnormal_autophagy | 2.06033937 |
| 15 | MP0001790_abnormal_immune_system | 2.05891273 |
| 16 | MP0005387_immune_system_phenotype | 2.05891273 |
| 17 | MP0002723_abnormal_immune_serum | 2.02076380 |
| 18 | MP0002398_abnormal_bone_marrow | 1.97773043 |
| 19 | MP0003172_abnormal_lysosome_physiology | 1.97028499 |
| 20 | MP0002419_abnormal_innate_immunity | 1.94852376 |
| 21 | MP0009745_abnormal_behavioral_response | 1.89874176 |
| 22 | MP0004510_myositis | 1.88511166 |
| 23 | MP0002064_seizures | 1.86669637 |
| 24 | MP0009785_altered_susceptibility_to | 1.86481011 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.84406324 |
| 26 | MP0005025_abnormal_response_to | 1.83948212 |
| 27 | MP0009764_decreased_sensitivity_to | 1.80813192 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.74757528 |
| 29 | MP0000716_abnormal_immune_system | 1.73854253 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.69417323 |
| 31 | MP0005451_abnormal_body_composition | 1.69128463 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.65107832 |
| 33 | MP0006082_CNS_inflammation | 1.60249230 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.59917566 |
| 35 | MP0009046_muscle_twitch | 1.57400946 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.57400637 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.55828792 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.54493840 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.54332647 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.52823378 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.51360025 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.50365892 |
| 43 | MP0002572_abnormal_emotion/affect_behav | 1.47556292 |
| 44 | MP0002722_abnormal_immune_system | 1.46162668 |
| 45 | MP0002405_respiratory_system_inflammati | 1.45857162 |
| 46 | MP0003329_amyloid_beta_deposits | 1.43322529 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.43160524 |
| 48 | MP0008469_abnormal_protein_level | 1.42254052 |
| 49 | MP0002429_abnormal_blood_cell | 1.40547673 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.39221296 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36982525 |
| 52 | MP0004270_analgesia | 1.34241971 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.32782307 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.27619205 |
| 55 | MP0003075_altered_response_to | 1.27576045 |
| 56 | MP0003866_abnormal_defecation | 1.27242530 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.26691266 |
| 58 | MP0000604_amyloidosis | 1.24605297 |
| 59 | MP0008569_lethality_at_weaning | 1.21981457 |
| 60 | MP0005310_abnormal_salivary_gland | 1.20437511 |
| 61 | MP0003828_pulmonary_edema | 1.19603865 |
| 62 | MP0002736_abnormal_nociception_after | 1.19305028 |
| 63 | MP0002009_preneoplasia | 1.18960061 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.18156236 |
| 65 | MP0008057_abnormal_DNA_replication | 1.17177430 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.15887386 |
| 67 | MP0001486_abnormal_startle_reflex | 1.15518122 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.15257840 |
| 69 | MP0002735_abnormal_chemical_nociception | 1.14641037 |
| 70 | MP0001970_abnormal_pain_threshold | 1.13169169 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.11537299 |
| 72 | MP0002272_abnormal_nervous_system | 1.11448339 |
| 73 | MP0002006_tumorigenesis | 1.09313959 |
| 74 | MP0003787_abnormal_imprinting | 1.07894717 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.07840875 |
| 76 | MP0004883_abnormal_blood_vessel | 1.06797814 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.06684105 |
| 78 | MP0001851_eye_inflammation | 1.06141846 |
| 79 | MP0001501_abnormal_sleep_pattern | 1.06076338 |
| 80 | MP0004381_abnormal_hair_follicle | 1.05913867 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.05504488 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.03682223 |
| 83 | MP0005058_abnormal_lysosome_morphology | 1.03599433 |
| 84 | MP0009278_abnormal_bone_marrow | 1.01599382 |
| 85 | MP0002132_abnormal_respiratory_system | 1.01564035 |
| 86 | MP0001853_heart_inflammation | 1.01098697 |
| 87 | MP0010307_abnormal_tumor_latency | 1.01067497 |
| 88 | MP0003448_altered_tumor_morphology | 1.00505041 |
| 89 | MP0001873_stomach_inflammation | 0.99480722 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.98954830 |
| 91 | MP0003633_abnormal_nervous_system | 0.98472769 |
| 92 | MP0000920_abnormal_myelination | 0.97982957 |
| 93 | MP0000343_altered_response_to | 0.97209959 |
| 94 | MP0009763_increased_sensitivity_to | 0.94774056 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.93465565 |
| 96 | MP0002067_abnormal_sensory_capabilities | 0.93410883 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.92670487 |
| 98 | MP0004924_abnormal_behavior | 0.92640214 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.92640214 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 0.90635143 |
| 101 | MP0003690_abnormal_glial_cell | 0.90609096 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.90575676 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.90092587 |
| 104 | MP0005166_decreased_susceptibility_to | 0.89904714 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.88616569 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.88616569 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.86260209 |
| 108 | MP0000858_altered_metastatic_potential | 0.83024788 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.82888729 |
| 110 | MP0000490_abnormal_crypts_of | 0.81195382 |
| 111 | MP0002822_catalepsy | 0.78238509 |
| 112 | MP0010094_abnormal_chromosome_stability | 0.78193761 |
| 113 | MP0008874_decreased_physiological_sensi | 0.78135971 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.77836038 |
| 115 | MP0001529_abnormal_vocalization | 0.76735931 |
| 116 | MP0004947_skin_inflammation | 0.75574706 |
| 117 | MP0003631_nervous_system_phenotype | 0.74781735 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.73665637 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.73503448 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.72361558 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.70685463 |
| 122 | MP0003724_increased_susceptibility_to | 0.70525287 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.69097067 |
| 124 | MP0008873_increased_physiological_sensi | 0.66710649 |
| 125 | MP0005164_abnormal_response_to | 0.66028596 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.63898342 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.61932293 |
| 128 | MP0000313_abnormal_cell_death | 0.57883212 |
| 129 | MP0008877_abnormal_DNA_methylation | 0.54094580 |
| 130 | MP0001663_abnormal_digestive_system | 0.53351309 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.52239358 |
| 132 | MP0008058_abnormal_DNA_repair | 0.51292281 |
| 133 | MP0006036_abnormal_mitochondrial_physio | 0.47611352 |
| 134 | MP0003795_abnormal_bone_structure | 0.46880860 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.46356263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.81088527 |
| 2 | Optic neuritis (HP:0100653) | 4.70052834 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.70052834 |
| 4 | Orchitis (HP:0100796) | 4.56839392 |
| 5 | Papilledema (HP:0001085) | 4.51352543 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.30967758 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.12305043 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.82506718 |
| 9 | Obstructive lung disease (HP:0006536) | 3.82506718 |
| 10 | Encephalitis (HP:0002383) | 3.74520066 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.58865000 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 3.58178844 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.40227910 |
| 14 | Urticaria (HP:0001025) | 3.29015885 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.27667523 |
| 16 | Focal motor seizures (HP:0011153) | 3.24542225 |
| 17 | Visual hallucinations (HP:0002367) | 3.23845519 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.19572108 |
| 19 | Disinhibition (HP:0000734) | 3.13544174 |
| 20 | Chronic otitis media (HP:0000389) | 3.12893740 |
| 21 | Cellulitis (HP:0100658) | 3.03049751 |
| 22 | Recurrent viral infections (HP:0004429) | 3.01684641 |
| 23 | Meningitis (HP:0001287) | 2.98169107 |
| 24 | Mutism (HP:0002300) | 2.94232335 |
| 25 | Stomatitis (HP:0010280) | 2.93933424 |
| 26 | Inappropriate behavior (HP:0000719) | 2.93635001 |
| 27 | Amyotrophic lateral sclerosis (HP:0007354) | 2.92842774 |
| 28 | Apathy (HP:0000741) | 2.91719603 |
| 29 | Diminished motivation (HP:0000745) | 2.88921975 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87243760 |
| 31 | Increased IgM level (HP:0003496) | 2.86785008 |
| 32 | Abnormality of binocular vision (HP:0011514) | 2.86624771 |
| 33 | Diplopia (HP:0000651) | 2.86624771 |
| 34 | Agnosia (HP:0010524) | 2.86154909 |
| 35 | IgM deficiency (HP:0002850) | 2.82481868 |
| 36 | Recurrent skin infections (HP:0001581) | 2.75813377 |
| 37 | Arterial thrombosis (HP:0004420) | 2.69571667 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67413799 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67413799 |
| 40 | Anorexia (HP:0002039) | 2.66843890 |
| 41 | Myositis (HP:0100614) | 2.65477682 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.63154996 |
| 43 | Gangrene (HP:0100758) | 2.61518768 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61461396 |
| 45 | Focal seizures (HP:0007359) | 2.61333483 |
| 46 | Acute hepatic failure (HP:0006554) | 2.60560457 |
| 47 | Granulocytopenia (HP:0001913) | 2.58246600 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57608546 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.57327187 |
| 50 | Abnormality of the prostate (HP:0008775) | 2.55969535 |
| 51 | Myokymia (HP:0002411) | 2.54795809 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50976609 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.48178341 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.46806056 |
| 55 | Pulmonary embolism (HP:0002204) | 2.46579494 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.42707969 |
| 57 | Amyloidosis (HP:0011034) | 2.41928388 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.41679607 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.39058390 |
| 60 | Thrombocytosis (HP:0001894) | 2.36488717 |
| 61 | Chest pain (HP:0100749) | 2.35053276 |
| 62 | Pustule (HP:0200039) | 2.33667981 |
| 63 | Supranuclear gaze palsy (HP:0000605) | 2.33657660 |
| 64 | Atonic seizures (HP:0010819) | 2.33462983 |
| 65 | Recurrent bronchitis (HP:0002837) | 2.32559391 |
| 66 | Combined immunodeficiency (HP:0005387) | 2.31481665 |
| 67 | Amaurosis fugax (HP:0100576) | 2.31263791 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29141602 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.28886033 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.27537239 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.25252129 |
| 72 | Glomerulopathy (HP:0100820) | 2.24786131 |
| 73 | Polyneuropathy (HP:0001271) | 2.22188444 |
| 74 | T lymphocytopenia (HP:0005403) | 2.20883270 |
| 75 | Gingival bleeding (HP:0000225) | 2.19888827 |
| 76 | Papilloma (HP:0012740) | 2.19296118 |
| 77 | Verrucae (HP:0200043) | 2.19296118 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.18609576 |
| 79 | Keratitis (HP:0000491) | 2.16172582 |
| 80 | Vasculitis (HP:0002633) | 2.13369740 |
| 81 | Abnormality of T cells (HP:0002843) | 2.13095450 |
| 82 | Fatigue (HP:0012378) | 2.12931565 |
| 83 | Increased IgE level (HP:0003212) | 2.11993068 |
| 84 | Episodic fever (HP:0001954) | 2.11462112 |
| 85 | Loss of speech (HP:0002371) | 2.11251737 |
| 86 | Epistaxis (HP:0000421) | 2.10200035 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08666134 |
| 88 | Thyroiditis (HP:0100646) | 2.07818270 |
| 89 | Abnormality of T cell number (HP:0011839) | 2.06830488 |
| 90 | Stereotypic behavior (HP:0000733) | 2.05379175 |
| 91 | Progressive inability to walk (HP:0002505) | 2.04624996 |
| 92 | Annular pancreas (HP:0001734) | 2.03968935 |
| 93 | Skin rash (HP:0000988) | 2.03017778 |
| 94 | Hemiplegia (HP:0002301) | 2.02332766 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.00715636 |
| 96 | Gingivitis (HP:0000230) | 2.00647426 |
| 97 | Petechiae (HP:0000967) | 1.99203409 |
| 98 | Absence seizures (HP:0002121) | 1.98535361 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.97259887 |
| 100 | Absent frontal sinuses (HP:0002688) | 1.97058515 |
| 101 | Vertigo (HP:0002321) | 1.96978879 |
| 102 | Epileptic encephalopathy (HP:0200134) | 1.95995109 |
| 103 | Depression (HP:0000716) | 1.93684419 |
| 104 | Skin ulcer (HP:0200042) | 1.92055918 |
| 105 | Lymphopenia (HP:0001888) | 1.91882404 |
| 106 | Impaired smooth pursuit (HP:0007772) | 1.91590940 |
| 107 | Colitis (HP:0002583) | 1.91340894 |
| 108 | Urinary urgency (HP:0000012) | 1.91004023 |
| 109 | Truncal ataxia (HP:0002078) | 1.90142922 |
| 110 | Hepatosplenomegaly (HP:0001433) | 1.87780862 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 1.87116518 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.87111235 |
| 113 | Poor eye contact (HP:0000817) | 1.86972432 |
| 114 | Memory impairment (HP:0002354) | 1.86860966 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.86805598 |
| 116 | Abnormality of oral frenula (HP:0000190) | 1.86643239 |
| 117 | Dialeptic seizures (HP:0011146) | 1.86329076 |
| 118 | Abnormality of B cell number (HP:0010975) | 1.86260165 |
| 119 | B lymphocytopenia (HP:0010976) | 1.86260165 |
| 120 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.85739771 |
| 121 | Broad-based gait (HP:0002136) | 1.85129162 |
| 122 | Lymphoma (HP:0002665) | 1.84456220 |
| 123 | Pointed chin (HP:0000307) | 1.84138991 |
| 124 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83666132 |
| 125 | Viral hepatitis (HP:0006562) | 1.83379138 |
| 126 | Spontaneous hematomas (HP:0007420) | 1.83107710 |
| 127 | IgG deficiency (HP:0004315) | 1.82712776 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81386166 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81386166 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81386166 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.78605817 |
| 132 | Cerebral inclusion bodies (HP:0100314) | 1.78169583 |
| 133 | Increased density of long bones (HP:0006392) | 1.74342396 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 1.73350725 |
| 135 | Eosinophilia (HP:0001880) | 1.73232847 |
| 136 | Sepsis (HP:0100806) | 1.70551122 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.70352413 |
| 138 | Leukocytosis (HP:0001974) | 1.69967490 |
| 139 | Ankyloglossia (HP:0010296) | 1.69401832 |
| 140 | Pulmonary infiltrates (HP:0002113) | 1.68539432 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.68210677 |
| 142 | Osteomyelitis (HP:0002754) | 1.67964830 |
| 143 | Hemoptysis (HP:0002105) | 1.67605617 |
| 144 | Basal cell carcinoma (HP:0002671) | 1.67570393 |
| 145 | Resting tremor (HP:0002322) | 1.66648549 |
| 146 | Nasal polyposis (HP:0100582) | 1.65646801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.11300451 |
| 2 | MAP3K9 | 3.30027970 |
| 3 | MAP4K1 | 3.23247927 |
| 4 | FES | 3.01069501 |
| 5 | GRK6 | 2.44319315 |
| 6 | MAP3K12 | 2.34606656 |
| 7 | SCYL2 | 2.16786474 |
| 8 | BLK | 2.14417646 |
| 9 | SIK3 | 2.08588808 |
| 10 | SIK2 | 2.00705560 |
| 11 | NTRK3 | 1.93853403 |
| 12 | MAP2K3 | 1.83244376 |
| 13 | IRAK4 | 1.80699962 |
| 14 | CDK19 | 1.79058891 |
| 15 | EPHA4 | 1.74823430 |
| 16 | MAP3K13 | 1.72642918 |
| 17 | SYK | 1.71899910 |
| 18 | FGR | 1.69552607 |
| 19 | ALK | 1.67797531 |
| 20 | KSR2 | 1.66749181 |
| 21 | CSF1R | 1.64960790 |
| 22 | MARK1 | 1.60706043 |
| 23 | CAMKK1 | 1.59569342 |
| 24 | MINK1 | 1.56968756 |
| 25 | TAOK3 | 1.56073288 |
| 26 | TXK | 1.55410313 |
| 27 | DAPK1 | 1.52736092 |
| 28 | TESK2 | 1.52114436 |
| 29 | ZAP70 | 1.38956469 |
| 30 | RPS6KA4 | 1.37009657 |
| 31 | CLK1 | 1.33529063 |
| 32 | HCK | 1.32531654 |
| 33 | BTK | 1.30098056 |
| 34 | YES1 | 1.29510210 |
| 35 | CSK | 1.25412415 |
| 36 | ITK | 1.24593198 |
| 37 | ERBB3 | 1.22431506 |
| 38 | EEF2K | 1.22031507 |
| 39 | PRPF4B | 1.21176393 |
| 40 | MAP3K4 | 1.18507877 |
| 41 | PKN2 | 1.17578497 |
| 42 | IKBKB | 1.14962773 |
| 43 | STK10 | 1.14327050 |
| 44 | KIT | 1.12700355 |
| 45 | LCK | 1.07519584 |
| 46 | CAMKK2 | 1.07088630 |
| 47 | DAPK2 | 1.03223284 |
| 48 | PAK6 | 1.02535580 |
| 49 | JAK3 | 1.01762851 |
| 50 | NTRK2 | 1.01159799 |
| 51 | MAP3K10 | 0.99306687 |
| 52 | TNK2 | 0.97373956 |
| 53 | TYK2 | 0.95888162 |
| 54 | CDC7 | 0.95304884 |
| 55 | TRIM28 | 0.93913042 |
| 56 | TEC | 0.92567659 |
| 57 | KSR1 | 0.92501246 |
| 58 | RAF1 | 0.91949409 |
| 59 | PDK1 | 0.91467664 |
| 60 | MAP3K5 | 0.89896225 |
| 61 | LYN | 0.88772201 |
| 62 | UHMK1 | 0.88770269 |
| 63 | CDK5 | 0.87748507 |
| 64 | MAP2K7 | 0.87579687 |
| 65 | IRAK2 | 0.86171533 |
| 66 | STK11 | 0.85993692 |
| 67 | TAOK2 | 0.83757442 |
| 68 | JAK1 | 0.83711779 |
| 69 | PNCK | 0.82950200 |
| 70 | TYRO3 | 0.80519352 |
| 71 | ACVR1B | 0.79870285 |
| 72 | TAOK1 | 0.78592684 |
| 73 | LRRK2 | 0.77747310 |
| 74 | CCNB1 | 0.76156529 |
| 75 | MARK3 | 0.76149163 |
| 76 | MAP3K1 | 0.73713449 |
| 77 | MAP3K11 | 0.73119831 |
| 78 | FYN | 0.72401463 |
| 79 | CDK6 | 0.71735420 |
| 80 | MAP3K3 | 0.71050331 |
| 81 | TBK1 | 0.68990671 |
| 82 | CDK15 | 0.68920135 |
| 83 | CDK18 | 0.67974484 |
| 84 | SRPK1 | 0.66206283 |
| 85 | CDK11A | 0.65732436 |
| 86 | IRAK1 | 0.65692282 |
| 87 | TESK1 | 0.63763707 |
| 88 | CDK14 | 0.63509703 |
| 89 | RET | 0.63174053 |
| 90 | MAP3K6 | 0.61600603 |
| 91 | DMPK | 0.60791368 |
| 92 | KDR | 0.60785368 |
| 93 | PRKCH | 0.60520850 |
| 94 | MATK | 0.57242667 |
| 95 | PLK2 | 0.56246466 |
| 96 | DYRK3 | 0.55742716 |
| 97 | TRIB3 | 0.55456893 |
| 98 | PIM1 | 0.55215941 |
| 99 | PIK3CG | 0.55186382 |
| 100 | MAP4K2 | 0.54262661 |
| 101 | EPHB1 | 0.54216077 |
| 102 | IRAK3 | 0.54170678 |
| 103 | GRK7 | 0.53280871 |
| 104 | JAK2 | 0.53245852 |
| 105 | NTRK1 | 0.52271491 |
| 106 | MAP2K4 | 0.51950529 |
| 107 | PRKCQ | 0.51588738 |
| 108 | EIF2AK3 | 0.50700221 |
| 109 | FLT3 | 0.49694416 |
| 110 | BCR | 0.47224520 |
| 111 | CDK4 | 0.46992129 |
| 112 | MAP3K8 | 0.46652701 |
| 113 | TSSK6 | 0.46594921 |
| 114 | PDPK1 | 0.46309924 |
| 115 | PAK4 | 0.46252466 |
| 116 | MAP3K14 | 0.45995286 |
| 117 | MAP3K2 | 0.45370702 |
| 118 | LIMK1 | 0.45076310 |
| 119 | IKBKE | 0.44162522 |
| 120 | STK16 | 0.41816744 |
| 121 | MAPK13 | 0.41187612 |
| 122 | ARAF | 0.40510700 |
| 123 | MAPK4 | 0.39574300 |
| 124 | ABL1 | 0.38948507 |
| 125 | ERN1 | 0.37450812 |
| 126 | HIPK2 | 0.36611993 |
| 127 | CSNK1G2 | 0.35554701 |
| 128 | EGFR | 0.34632041 |
| 129 | BMPR2 | 0.34604102 |
| 130 | TGFBR2 | 0.32662979 |
| 131 | FGFR3 | 0.32285899 |
| 132 | PRKCD | 0.31223713 |
| 133 | MAPK12 | 0.30442902 |
| 134 | MST4 | 0.29765861 |
| 135 | OXSR1 | 0.29440324 |
| 136 | RPS6KA2 | 0.29139620 |
| 137 | IGF1R | 0.26117930 |
| 138 | NEK6 | 0.22871092 |
| 139 | STK24 | 0.19937315 |
| 140 | TRPM7 | 0.19616236 |
| 141 | MAP2K6 | 0.19550603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.33469428 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90677648 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01730630 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98500852 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96515124 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89067781 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.88516077 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.84438191 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70111469 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68933061 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60276270 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54718553 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47726671 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.45531577 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44749317 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.42374253 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41039239 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.40417683 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40132147 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33284516 |
| 21 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28405297 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.26631186 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26033898 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25646620 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.25571057 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24608818 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23909019 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.23678050 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19282818 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.18127683 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.16957824 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.16103094 |
| 33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15044562 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10269279 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.07959542 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.06626576 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06239176 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04791595 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04172912 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.03395944 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02178120 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99440779 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99271950 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98902779 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.98804301 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98126648 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.98120899 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97898707 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.97606313 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96656293 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.95618197 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95502608 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93726875 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93392218 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93150522 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.92185285 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90819486 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90715600 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89730279 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89571602 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89297400 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89225961 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.87923932 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87703067 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87414528 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.86018270 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85957575 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.85850306 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85460629 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84659907 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84435549 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84294382 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80613256 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79602684 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.79046660 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.78663536 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78444248 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78010972 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77241620 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77054489 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76985352 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76461978 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76455244 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76211437 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76206227 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75666298 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.75223130 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75086027 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72646274 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72244192 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71367645 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70165592 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.69689633 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.69357723 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68233534 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67611985 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67492074 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.67080301 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65842071 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65288996 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.64524578 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63960467 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63871262 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63774857 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61420873 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61345485 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61280840 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.61059571 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60839951 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60038747 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59987967 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59629539 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58651893 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57769395 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.57703305 |
| 116 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57065612 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56364240 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56117313 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55717665 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55657395 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55406446 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37968130 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37473490 |
| 124 | Spliceosome_Homo sapiens_hsa03040 | 0.32263670 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27714814 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26156998 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23041901 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22843887 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15816206 |
| 130 | RNA degradation_Homo sapiens_hsa03018 | 0.15246766 |
| 131 | Mismatch repair_Homo sapiens_hsa03430 | 0.13506458 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11571489 |
| 133 | Homologous recombination_Homo sapiens_hsa03440 | 0.09845597 |
| 134 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08850842 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07721213 |
| 136 | RNA transport_Homo sapiens_hsa03013 | 0.06390368 |

